AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20061402 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab plus interferon (IFN)‐alpha2a (IRC analysis)
Number of subjects: 649
Study 20061402 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus interferon (IFN)‐alpha2a (IRC analysis)
Number of subjects: 649
Study 20061402 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab plus interferon (IFN)‐alpha2b
Number of subjects: 649
Study 20061402 — intervention group
Group type: COMPARATOR
Intervention: Interferon (IFN)‐alpha2b alone
Number of subjects: 649
Study 20061402 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab treatment
Number of subjects: 649
Study 20061402 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 649
Study 18376260 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg lansoprazole once per day (group A)
Number of subjects: 30
Study 18376260 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg lansoprazole twice per day (group B)
Number of subjects: 30
Study 18376260 — intervention group
Group type: COMPARATOR
Intervention: Extensively hydrolyzed formula (group C)
Number of subjects: 30
Study 16926224 — intervention group
Group type: EXPERIMENTAL
Intervention: Z-100 2 microg
Number of subjects: 116
Study 16926224 — intervention group
Group type: EXPERIMENTAL
Intervention: Z-100 20 microg
Number of subjects: 116
Study 16926224 — intervention group
Group type: EXPERIMENTAL
Intervention: Z-100 40 microg
Number of subjects: 116
Study 16926224 — intervention group
Group type: COMPARATOR
Intervention: Z-100
Number of subjects: 116
Study 12667306 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with Isorel biotherapy (29 patients)
Number of subjects: 64
Study 12667306 — intervention group
Group type: COMPARATOR
Intervention: Only chemotherapy (21 patients)
Number of subjects: 64
Study 12667306 — intervention group
Group type: COMPARATOR
Intervention: Only surgery (14 patients)
Number of subjects: 64
Study 10894870 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide 800 mg (escalated to 1,200 mg)
Number of subjects: 28
Study 10894870 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide 200 mg
Number of subjects: 28
Study 10894870 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 28
Study 8662160 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-enhanced computed tomography (CT)
Number of subjects: 24
Study 8662160 — intervention group
Group type: COMPARATOR
Intervention: Cine pulmonary arteriography (gold standard)
Number of subjects: 24
Study 1465754 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled bradykinin (8 mg/ml)
Number of subjects: 10
Study 1465754 — intervention group
Group type: COMPARATOR
Intervention: Vehicle placebo
Number of subjects: 10
Study 6376959 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloid group
Number of subjects: 27
Study 6376959 — intervention group
Group type: COMPARATOR
Intervention: Crystalloid group
Number of subjects: 27
Study 31801567 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (1.5 g), Thiamine (100 mg), and Hydrocortisone (50 mg) given every 6 h for up to 16 doses
Number of subjects: 501
Study 31801567 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 501
Study 28000377 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief family-centred care (BFCC) programme
Number of subjects: 47
Study 28000377 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 47
Study 27155848 — intervention group
Group type: COMPARATOR
Intervention: Exercise without n-3 supplementation (EX)
Number of subjects: 10
Study 27155848 — intervention group
Group type: COMPARATOR
Intervention: Exercise with n-3 supplementation (EX + n-3)
Number of subjects: 10
Study 27155848 — intervention group
Group type: COMPARATOR
Intervention: Exercise (EX)
Number of subjects: 10
Study 27155848 — intervention group
Group type: COMPARATOR
Intervention: Rest with n-3 supplementation (R + n-3)
Number of subjects: 10
Study 24462479 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-session 12-step facilitation therapy (TSF)
Number of subjects: 121
Study 24462479 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 121
Study 23171020 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined oral azithromycin (10 mg/kg/d) plus allopurinol (10 mg/kg/d) for two months
Number of subjects: 86
Study 23171020 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular Glucantime (20 mg/kg of antimony daily for 20 days)
Number of subjects: 86
Study 20209393 — intervention group
Group type: COMPARATOR
Intervention: One distal locking screw
Number of subjects: 57
Study 20209393 — intervention group
Group type: EXPERIMENTAL
Intervention: Two distal locking screws
Number of subjects: 57
Study 17667021 — intervention group
Group type: EXPERIMENTAL
Intervention: Pursed-lips breathing
Number of subjects: 40
Study 17667021 — intervention group
Group type: EXPERIMENTAL
Intervention: Expiratory muscle training
Number of subjects: 40
Study 17667021 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study 15565575 — intervention group
Group type: EXPERIMENTAL
Intervention: DCC method for scoring estrogen receptor (ER)
Number of subjects: 402
Study 15565575 — intervention group
Group type: EXPERIMENTAL
Intervention: All IHC methods for scoring ER
Number of subjects: 402
Study 15565575 — intervention group
Group type: EXPERIMENTAL
Intervention: Any‐or‐none IHC method
Number of subjects: 402
Study 15565575 — intervention group
Group type: EXPERIMENTAL
Intervention: PR scores
Number of subjects: 402
Study 11883973 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharyngeal pack inserted
Number of subjects: 62
Study 11883973 — intervention group
Group type: COMPARATOR
Intervention: No pharyngeal pack inserted
Number of subjects: 62
Study 10521861 — intervention group
Group type: EXPERIMENTAL
Intervention: Autoregressive models fitted using BUGS
Number of subjects: 0
Study 10521861 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian approach using BUGS
Number of subjects: 0
Study 7497685 — intervention group
Group type: EXPERIMENTAL
Intervention: Articulating spacer with antibiotic-impregnated cement
Number of subjects: 26
Study 1827368 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tetracycline (Topicycline)
Number of subjects: 69
Study 1827368 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% benzoyl-peroxide gel
Number of subjects: 69
Study 1827368 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral oxytetracycline (250 mg twice daily)
Number of subjects: 69
Study 7040493 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumetanide (1 mg, increased to a maximum of 10 mg daily)
Number of subjects: 0
Study 7040493 — intervention group
Group type: COMPARATOR
Intervention: Furosemide (40 mg, increased to a maximum of 400 mg daily)
Number of subjects: 0
Study 31805932 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct medical costs of type 2 diabetes
Number of subjects: 628
Study 31805932 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare costs for patients with complications
Number of subjects: 628
Study 31805932 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment costs due to complications
Number of subjects: 628
Study 31805932 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare costs due to hospital admissions
Number of subjects: 628
Study 31805932 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect costs due to absenteeism
Number of subjects: 628
Study 27744016 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured, individual sports program (Group B)
Number of subjects: 77
Study 27744016 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory physiotherapeutical supervision (Group C)
Number of subjects: 77
Study 27744016 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Group A)
Number of subjects: 77
Study 27744016 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 77
Study 25341064 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermatome technique with soft tissue removal
Number of subjects: 47
Study 25341064 — intervention group
Group type: COMPARATOR
Intervention: Linear incision with no soft tissue reduction
Number of subjects: 47
Study 23123494 — intervention group
Group type: EXPERIMENTAL
Intervention: Prototype dentifrice containing 5000ppm fluoride and 2% PVM/MA copolymers (PVD)
Number of subjects: 60
Study 23123494 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate(®) Total Sensitive (CTS, 1100ppm fluoride)
Number of subjects: 60
Study 23123494 — intervention group
Group type: EXPERIMENTAL
Intervention: ProNamel(®) (PRN, 1450ppm fluoride)
Number of subjects: 60
Study 23123494 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 60
Study 22075239 — intervention group
Group type: EXPERIMENTAL
Intervention: Signs emphasizing patient safety
Number of subjects: 2
Study 22075239 — intervention group
Group type: COMPARATOR
Intervention: Signs emphasizing personal safety
Number of subjects: 2
Study 19656022 — intervention group
Group type: EXPERIMENTAL
Intervention: Ridge angles <28 degrees
Number of subjects: 20
Study 19656022 — intervention group
Group type: EXPERIMENTAL
Intervention: Presurgical ridge angle
Number of subjects: 20
Study 17379006 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (PIO)
Number of subjects: 125
Study 17379006 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone and Simvastatin (PIO/SIM)
Number of subjects: 125
Study 17379006 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin (SIM)
Number of subjects: 125
Study 15040805 — intervention group
Group type: EXPERIMENTAL
Intervention: verum acupuncture
Number of subjects: 900
Study 15040805 — intervention group
Group type: COMPARATOR
Intervention: sham acupuncture
Number of subjects: 900
Study 15040805 — intervention group
Group type: COMPARATOR
Intervention: conservative standard therapy
Number of subjects: 900
Study 11847411 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethylstarch (HAES steril 10%, HES)
Number of subjects: 20
Study 11847411 — intervention group
Group type: COMPARATOR
Intervention: NaCl 0.9% solution
Number of subjects: 20
Study 9751331 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous nephrostomy
Number of subjects: 42
Study 9751331 — intervention group
Group type: COMPARATOR
Intervention: Retrograde ureteral catheterization
Number of subjects: 42
Study 7946687 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol 320 mg I/ml
Number of subjects: 102
Study 7946687 — intervention group
Group type: COMPARATOR
Intervention: Ioxaglate 320 mg I/ml
Number of subjects: 102
Study 2954166 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-minute complete back massage
Number of subjects: 21
Study 2954166 — intervention group
Group type: COMPARATOR
Intervention: Control Group (rested, no massage)
Number of subjects: 21
Study 31809325 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous open label placebo
Number of subjects: 32
Study 29490509 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg
Number of subjects: 494
Study 29490509 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.2 mg
Number of subjects: 494
Study 29490509 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 494
Study 27645554 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based memory rehabilitation
Number of subjects: 20
Study 27645554 — intervention group
Group type: COMPARATOR
Intervention: Self-help control group
Number of subjects: 20
Study 25575640 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunomodulating enteral nutrition formula (IEN, n = 13, Impact(®), Nestlé)
Number of subjects: 28
Study 25575640 — intervention group
Group type: COMPARATOR
Intervention: Standard enteral nutrition formula (SEN, n = 15)
Number of subjects: 28
Study 22988905 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 257
Study 20433733 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical traction with extension-oriented treatment approach
Number of subjects: 120
Study 20433733 — intervention group
Group type: COMPARATOR
Intervention: Extension-oriented treatment approach without mechanical traction
Number of subjects: 120
Study 18352997 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 23
Study 18352997 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 23
Study 16554199 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial endodontic treatment
Number of subjects: 532
Study 14598667 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 0.05 mg
Number of subjects: 40
Study 14598667 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal saline (control group)
Number of subjects: 40
Study 11313095 — intervention group
Group type: EXPERIMENTAL
Intervention: HF‐rTMS at 90% of the motor threshold on the left prefrontal cortex
Number of subjects: 40
Study 11313095 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 40
Study 9452847 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 50
Study 9452847 — intervention group
Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 50
Study 7892081 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined schedule of inactivated polio vaccine followed by two doses of live attenuated oral polio vaccine
Number of subjects: 193
Study 7892081 — intervention group
Group type: COMPARATOR
Intervention: Live attenuated oral polio vaccine (three doses)
Number of subjects: 193
Study 3258660 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated polyribosyl ribitol phosphate (PRP) vaccine
Number of subjects: 0
Study 3258660 — intervention group
Group type: COMPARATOR
Intervention: Unconjugated polyribosyl ribitol phosphate (PRP) vaccine
Number of subjects: 0
Study 30980421 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol/phenytoin gel treatment on two wounds
Number of subjects: 19
Study 30980421 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-topically treated wounds in misoprostol/phenytoin group
Number of subjects: 19
Study 30980421 — intervention group
Group type: COMPARATOR
Intervention: Control untreated wounds
Number of subjects: 19
Study 29131722 — intervention group
Group type: EXPERIMENTAL
Intervention: Congruent health message (gain vs. loss frame) with high perceived message quality
Number of subjects: 109
Study 29131722 — intervention group
Group type: EXPERIMENTAL
Intervention: Congruent health message (gain vs. loss frame) with low perceived message quality
Number of subjects: 109
Study 29131722 — intervention group
Group type: EXPERIMENTAL
Intervention: Incongruent health message (gain vs. loss frame) with high perceived message quality
Number of subjects: 109
Study 29131722 — intervention group
Group type: EXPERIMENTAL
Intervention: Incongruent health message (gain vs. loss frame) with low perceived message quality
Number of subjects: 109
Study 25179488 — intervention group
Group type: EXPERIMENTAL
Intervention: Videoplethysmographic (VPG) signal
Number of subjects: 11
Study 25179488 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrocardiogram (ECG) signals
Number of subjects: 11
Study 25179488 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse Harmonic Strength (PHS)
Number of subjects: 11
Study 25179488 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic ECG-based measurements
Number of subjects: 11
Study 22752659 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic syndrome adults
Number of subjects: 0
Study 22752659 — intervention group
Group type: COMPARATOR
Intervention: Healthy adults
Number of subjects: 0
Study 22752659 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 21555294 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated blood pressure devices (ABPDs)
Number of subjects: 99
Study 21555294 — intervention group
Group type: COMPARATOR
Intervention: Home blood pressure device (HBPD)
Number of subjects: 99
Study 18651881 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal pelvic floor muscle training (PFMT)
Number of subjects: 164
Study 18651881 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 164
Study 17032160 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Assisted Cognitive Treatment (MACT)
Number of subjects: 30
Study 17032160 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 30
Study 14667670 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive vein harvest techniques
Number of subjects: 14
Study 14667670 — intervention group
Group type: COMPARATOR
Intervention: Conventional vein harvest techniques
Number of subjects: 14
Study 11066029 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucolytic medication
Number of subjects: 159
Study 9337828 — intervention group
Group type: EXPERIMENTAL
Intervention: Exhalation at an expiratory flow rate of 250 ml/min
Number of subjects: 10
Study 9337828 — intervention group
Group type: EXPERIMENTAL
Intervention: Exhalation at an expiratory flow rate of 1100 ml/min
Number of subjects: 10
Study 9337828 — intervention group
Group type: EXPERIMENTAL
Intervention: Water consumption (hot or cold)
Number of subjects: 10
Study 9337828 — intervention group
Group type: EXPERIMENTAL
Intervention: Sampling from a low NO reservoir system
Number of subjects: 10
Study 7684542 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital rectal examination (DRE)
Number of subjects: 0
Study 7684542 — intervention group
Group type: EXPERIMENTAL
Intervention: Ejaculation
Number of subjects: 0
Study 7684542 — intervention group
Group type: COMPARATOR
Intervention: Control group (no DRE or ejaculation)
Number of subjects: 0
Study 30626496 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy plus usual care
Number of subjects: 60
Study 30626496 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 60
Study 29178728 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-low abrasivity dentifrice (5% w/w KNO3, 5% w/w STP, 1,100 ppm fluoride as sodium fluoride; RDA10)
Number of subjects: 168
Study 29178728 — intervention group
Group type: COMPARATOR
Intervention: Moderate abrasivity fluoride dentifrice (1,100 ppm fluoride as sodium monofluorophosphate; RDA68)
Number of subjects: 168
Study 29178728 — intervention group
Group type: COMPARATOR
Intervention: Higher abrasivity daily-use whitening dentifrice (1,100 ppm fluoride as sodium fluoride; RDA137)
Number of subjects: 168
Study 25711173 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP
Number of subjects: 32
Study 25711173 — intervention group
Group type: COMPARATOR
Intervention: FM/RME
Number of subjects: 32
Study 25711173 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study 24014214 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate 100 mg/day for 5 days plus uFSH 37.5 IU/day
Number of subjects: 174
Study 24014214 — intervention group
Group type: COMPARATOR
Intervention: uFSH 37.5 IU/day
Number of subjects: 174
Study 22111524 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-hour course with interactive training for practice nurses delivered over 4 afternoons and one 1/2 hour visit to the practice over 10 months.
Number of subjects: 4034
Study 18751491 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical hand antisepsis solutions (specific solutions not mentioned)
Number of subjects: 0
Study 16021004 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II lenses soaked in polyhexamethylene biguanide-based systems
Number of subjects: 0
Study 16021004 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone hydrogel lenses soaked in regimen 4
Number of subjects: 0
Study 16021004 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen 1 with group II lenses
Number of subjects: 0
Study 12865477 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (80 mg twice daily)
Number of subjects: 76
Study 12865477 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 9890362 — intervention group
Group type: EXPERIMENTAL
Intervention: Curriculum-plus-CYS intervention (Reach for Health Community Youth Service program)
Number of subjects: 972
Study 9890362 — intervention group
Group type: COMPARATOR
Intervention: Curriculum-only intervention
Number of subjects: 972
Study 9890362 — intervention group
Group type: EXPERIMENTAL
Intervention: CYS intervention
Number of subjects: 972
Study 8694165 — intervention group
Group type: EXPERIMENTAL
Intervention: Syntocinon (1 ml, 10 units)
Number of subjects: 64
Study 8694165 — intervention group
Group type: COMPARATOR
Intervention: Saline (1 ml, placebo)
Number of subjects: 64
Study 1905592 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release diltiazem 180 mg b.i.d.
Number of subjects: 60
Study 1905592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 6410280 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling plus supportive‐expressive psychotherapy (SE)
Number of subjects: 110
Study 6410280 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling plus cognitive‐behavioral psychotherapy (CB)
Number of subjects: 110
Study 6410280 — intervention group
Group type: COMPARATOR
Intervention: Drug counseling alone (DC)
Number of subjects: 110
Study 31039600 — intervention group
Group type: EXPERIMENTAL
Intervention: Gold AQ (Sinocare)
Number of subjects: 120
Study 31039600 — intervention group
Group type: EXPERIMENTAL
Intervention: Freestyle Optium Xceed (Abbott)
Number of subjects: 120
Study 31039600 — intervention group
Group type: EXPERIMENTAL
Intervention: Contour TS (Bayer)
Number of subjects: 120
Study 31039600 — intervention group
Group type: EXPERIMENTAL
Intervention: OneTouch Ultra (J&J)
Number of subjects: 120
Study 31039600 — intervention group
Group type: EXPERIMENTAL
Intervention: Accu‐Chek Performa (Roche)
Number of subjects: 120
Study 31868694 — intervention group
Group type: EXPERIMENTAL
Intervention: Horse-riding therapy (H-RT)
Number of subjects: 123
Study 31868694 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythm and music-based therapy (R-MT)
Number of subjects: 123
Study 31868694 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 123
Study 29311155 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin therapy
Number of subjects: 14671
Study 29311155 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14671
Study 29311155 — intervention group
Group type: EXPERIMENTAL
Intervention: SHEs
Number of subjects: 14671
Study 29311155 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonfatal myocardial infarction
Number of subjects: 14671